DE2126304B2 - 1-AcyIthiosemicarbazide substituted in 4-control, process for their preparation and pharmaceuticals containing them - Google Patents

1-AcyIthiosemicarbazide substituted in 4-control, process for their preparation and pharmaceuticals containing them

Info

Publication number
DE2126304B2
DE2126304B2 DE19712126304 DE2126304A DE2126304B2 DE 2126304 B2 DE2126304 B2 DE 2126304B2 DE 19712126304 DE19712126304 DE 19712126304 DE 2126304 A DE2126304 A DE 2126304A DE 2126304 B2 DE2126304 B2 DE 2126304B2
Authority
DE
Germany
Prior art keywords
substituted
acylthiosemicarbazides
mol
carboxylic acid
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19712126304
Other languages
German (de)
Other versions
DE2126304A1 (en
DE2126304C3 (en
Inventor
Helmut Dipl.- Chem. Dr. Ddr 1071 Berlin Just
Justus Dipl.-Chem. Dr. Ddr 1160 Berlin Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlin Chemie AG
Original Assignee
Berlin Chemie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie AG filed Critical Berlin Chemie AG
Publication of DE2126304A1 publication Critical patent/DE2126304A1/en
Publication of DE2126304B2 publication Critical patent/DE2126304B2/en
Application granted granted Critical
Publication of DE2126304C3 publication Critical patent/DE2126304C3/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description

4ri4 r i

Bisher sind virustatisch wirksame Abkömmlinge des Thiosemicarbazids nur in Form der Thiosemicarbazone des Isatins (Marboran) bekannt. i-Acyl-4-allylthiosemicarbazide werden von G a g i u et al., j. pr. Ch. 36, S. 108 (1967), aus Carbonsäurehydraziden und Allylisothiocya- ■» nat als Vorstufe für 1,3,4-Thiadiazole synthetisiert, eine therapeutische Wirkung dieser 1-Acylthiosemicarbazide ist nicht nachgewiesen. Ferner sind Turberkulostatika beschrieben u.a. l-(2-Hydroxybenzoyl)-4-n-butylthiosemicarbazid von M. H. S h a h, J. Sei. Ind. Rese- wi arch 190, 68-70 (1960), sowie u.a. l-Benzoyl-4-naphthyl-(l)-thiosemicarbazid von Buu —Hoi (Bull. Soc. chim. France 1956, S. 363-9).So far, virustatically effective derivatives of thiosemicarbazide are only in the form of thiosemicarbazones des isatin (marborane) known. i-Acyl-4-allylthiosemicarbazide are by G a g i u et al., j. pr. Ch. 36, p. 108 (1967), from carboxylic acid hydrazides and allylisothiocya- ■ » nat synthesized as a precursor for 1,3,4-thiadiazoles, a therapeutic effect of these 1-acylthiosemicarbazides is not proven. Turberculostatics are also described, including l- (2-hydroxybenzoyl) -4-n-butylthiosemicarbazide by M. H. S h a h, J. Sei. Ind. Resewi arch 190, 68-70 (1960), as well as, inter alia, l-benzoyl-4-naphthyl- (l) -thiosemicarbazide von Buu-Hoi (Bull. Soc. chim. France 1956, pp. 363-9).

Die Erfindung bezweckt die Erweiterung dieser Stoffklasse zur Erschließung neuer Anwendungsberei- t,r> ehe dieser Verbindungen.The invention aims at expanding this class to open up new fields of application t, r> before these compounds.

Es wurde gefunden, daß die aliphatische und aromatische Isothiocyanate mit Carbonsäurehydrazi1 - Adamantoyl-( 1 J^-cyclohexylthiosemicarbazid,
F. 234° C, 89%
It has been found that the aliphatic and aromatic isothiocyanates with Carbonsäurehydrazi1 - Adamantoyl- (1 J ^ -cyclohexylthiosemicarbazid,
F. 234 ° C, 89%

2.42.4

l-Cinnamoyl-4-n-butylthiosemicarbazid,
F. 169° C, 64%
l-cinnamoyl-4-n-butylthiosemicarbazide,
F. 169 ° C, 64%

1 -Adamantoyl-( 1 )-4-n-butylthiosemicarbazid,
F. 195° C, 79%
1-adamantoyl- (1) -4-n-butylthiosemicarbazide,
195 ° C, 79%

1-(4-Chlorphenoxyacetyl)-4-n-butylthiosemicarbazid,
F. 165° C, 82%
1- (4-chlorophenoxyacetyl) -4-n-butylthiosemicarbazide,
F. 165 ° C, 82%

l-Adamantoyl-(l)-4-phenylthiosemicarbazid,
F. 182° C, 38%
l-adamantoyl- (l) -4-phenylthiosemicarbazide,
F. 182 ° C, 38%

i-Cinnamoyl-4-cyclohexylthiosemicarbazid,
F.202bis204°C,81%
i-cinnamoyl-4-cyclohexylthiosemicarbazide,
F.202 to 204 ° C, 81%

2.92.9

1-(4-Chlorphenoxyacetyl)-4-cyclohexylthiosemicarbazid, F. 187 bis 188° C, 83%1- (4-chlorophenoxyacetyl) -4-cyclohexylthiosemicarbazide, m.p. 187 to 188 ° C, 83%

2.102.10

1-(4-Nitrobenzoyl)-4-phenylthioseniicarbazid,
F. 164 bis 66° C, 88°/.)
1- (4-nitrobenzoyl) -4-phenylthioseniicarbazide,
F. 164 to 66 ° C, 88 ° /.)

Claims (10)

Patentansprüche:Patent claims: 1. In 4-Stellung substituierte 1 -Acylthiosemicarbazide der allgemeinen Fjrmel1. 1-Acylthiosemicarbazides substituted in the 4-position of the general fjrmel R1—C —NH-NH-C—NH-R2 R 1 -C-NH-NH-C-NH-R 2 Il IlIl Il ο sο s in derin the Ri = 4-Nitrophenyl-, Styryl-, Adamantyl-(l)-, 4-Chlor-phenoxymethyl- oder Carbäthoxy-und R2 = Phenyl-, Cyclohexyl- oder η-Butyl- sein kann,Ri = 4-nitrophenyl-, styryl-, adamantyl- (l) -, 4-chloro-phenoxymethyl- or carbethoxy- and R 2 = phenyl-, cyclohexyl- or η-butyl- can be, wobei für den Fall, daß R1 = Styryl- bedeutet, R2 nur für Cyclohexyl- oder η-Butyl- steht, und für den Fall, daß R1 = Carbäthoxy- bedeutet, R2 für Phenylsteht where for the case that R 1 = styryl-, R 2 only stands for cyclohexyl- or η-butyl-, and for the case that R 1 = carbethoxy-, R 2 stands for phenyl 2. Verfahren zur Herstellung von 1-Acylthiosemicarbaziden gemäß Anspruch 1, dadurch gekennzeichnet, daß man in an sich bekannter Weise Carbonsäurechloride der allgemeinen Formel2. Process for the preparation of 1-acylthiosemicarbazides according to claim 1, characterized in that carboxylic acid chlorides of the general formula are used in a manner known per se R1—C—ClR 1 -C Cl Il οIl ο in der R1 die angegebene Bedeutung hat, mit Thiosemicarbaziden der allgemeinen Formelin which R 1 has the meaning given, with thiosemicarbazides of the general formula H2N-NH-C-NH-R2 H 2 N-NH-C-NH-R 2 in der R2 die angegebene Bedeutung hat, bzw. indem man Carbonsäurehydrazide der allgemeinen Formelin which R 2 has the meaning given, or by using carboxylic acid hydrazides of the general formula R1—C-NH-NH2 R 1 -C-NH-NH 2 in denen R1 die angegebene Bedeutung hat, mit Isothiocyanaten der allgemeinen Formelin which R 1 has the meaning given, with isothiocyanates of the general formula S=C=N-R2 S = C = NR 2 in denen R2 die angegebene Bedeutung hat, umsetzt. in which R 2 has the meaning given, converts. 3. Arzneimittel enthaltend 1 -Acylthiosemicarbazide gemäß Anspruch 1 in Mischung mit pharmazeutisch verträglichen Träger- und Hilfsstoffen.3. Medicinal products containing 1-acylthiosemicarbazide according to claim 1 in a mixture with pharmaceutically acceptable carriers and auxiliaries. den bzw. in 4-Stellung substituierte Thiosemicarbazide mit Carbonsäurechloriden in an sich bekannter Weise zu neuen 4-substituierten 1-Acylthiosemicarbaziden umsetzen lassen. Diese Verbindungen zeigen überra- -:. sehend virustatische Wirksamkeitthiosemicarbazides substituted in the 4-position with carboxylic acid chlorides in a manner known per se to new 4-substituted 1-acylthiosemicarbazides have it implemented. These connections show sur- - :. seeing virustatic effectiveness Beispiel 1.0Example 1.0 6,6 g (0,05 Mol) Oxalsäureäthylestermonohydrazid werden in möglichst wenig Äthanol warm gelöst und6.6 g (0.05 mol) of ethyl oxalate monohydrazide are dissolved warm in as little ethanol as possible and in unter Rühren 7,5 g (0,055 Mol) Phenylisothiocyanat, im gleichen Volumen Äthanol gelöst, zugetropfL Nach kurzer Zeit tritt Fällung ein. Es wird noch 1 Stunde unter Rückfluß erhitzt, nach dem Abkühlen abgesaugt und aus Äthanol umkristallisiert.in with stirring 7.5 g (0.055 mol) of phenyl isothiocyanate, im dissolved in the same volume of ethanol, added dropwise Precipitation occurs for a short time. It is heated under reflux for a further 1 hour, filtered off with suction after cooling and off Recrystallized ethanol. |? Ausbeute an l-Carbäthoxycarbonyl-4-phenylthiosemicarbazid 11,5 g = 88%; F. 153-54°C. |? Yield of 1-carbethoxycarbonyl-4-phenylthiosemicarbazide 11.5 g = 88%; 153-54 ° C. Beispiel 2.1Example 2.1 10 g (0,058 Mol) 4-CycIohexylthiosemicarbazid wer-10 g (0.058 mol) of 4-CycIohexylthiosemicarbazid are 2" den in 60 ml Chloroform warm gelöst und 11,9 g (0,064 Mol) 4-Nitro-benzoylchlorid in 30 ml Chloroform gelöst unter Rühren zugetropft Es wird noch 3 Stunden unter Rückfluß erhitzt, wobei schwache HCI-Entwicklung auftritt. Nach dem Abkühlen wird abgesaugt und aus Dissolved 2 "den in 60 ml of warm chloroform and 11.9 g (0.064 mol) of 4-nitro-benzoyl chloride dissolved in 30 ml of chloroform added dropwise with stirring. The mixture is heated under reflux for a further 3 hours, with slight evolution of HCl. After cooling is sucked off and off -r> Essigsäure umkristallisiert. - r > acetic acid recrystallized. Ausbeute an l-^-Nitrobenzoyl^-cyclohexylthiosemicarbazid 13 g = 40%; F. 2030C.Yield of 1- ^ - nitrobenzoyl ^ -cyclohexylthiosemicarbazide 13 g = 40%; F. 203 0 C. Analog zu Beispiel 1.0 und 2.1 wurden folgende in iii 4-Stellung substituierte 1 -Acylthiosemicarbazide aus den entsprechenden Isothiocyanaten und Carbonsäurehydraziden bzw. aus 4-substituierten Thiosemicarbaziden und Säurechloriden hergestellt.Analogously to Examples 1.0 and 2.1, the following 1-acylthiosemicarbazides, substituted in the 4-position iii, were obtained the corresponding isothiocyanates and carboxylic acid hydrazides or from 4-substituted thiosemicarbazides and acid chlorides. 2.22.2 l-(4-Chlorphenoxyacetyl)-4-phenylthiosemicarbazid,
F. 192°C,91%
l- (4-chlorophenoxyacetyl) -4-phenylthiosemicarbazide,
192 ° C, 91%
4040
DE19712126304 1970-07-14 1971-05-27 1-Acylthiosemicarbazides substituted in the 4-position, process for their preparation and medicaments containing them Expired DE2126304C3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD14880370 1970-07-14

Publications (3)

Publication Number Publication Date
DE2126304A1 DE2126304A1 (en) 1972-01-20
DE2126304B2 true DE2126304B2 (en) 1979-03-29
DE2126304C3 DE2126304C3 (en) 1979-11-15

Family

ID=5482717

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712126304 Expired DE2126304C3 (en) 1970-07-14 1971-05-27 1-Acylthiosemicarbazides substituted in the 4-position, process for their preparation and medicaments containing them

Country Status (5)

Country Link
CH (2) CH548990A (en)
DE (1) DE2126304C3 (en)
FR (1) FR2097737A5 (en)
HU (2) HU164570B (en)
SU (2) SU687069A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134914A (en) * 1975-08-25 1979-01-16 Eli Lilly And Company 1-Acyl-4-substituted phenyl thiosemicarbazides
GR69827B (en) * 1978-09-14 1982-07-13 Gulf Oil Corp
US4405791A (en) * 1979-12-10 1983-09-20 Gulf Oil Corporation Arylthioureido pyridinecarbamino compounds and use as plant growth regulants
AU2948189A (en) * 1987-12-31 1989-08-01 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
US6924312B2 (en) 2001-07-10 2005-08-02 Synta Pharmaceuticals Corp. Taxol enhancer compounds
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI252847B (en) 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI332943B (en) 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
JP5362986B2 (en) 2004-06-23 2013-12-11 シンタ ファーマスーティカルズ コーポレイション Bis (thio-hydrazide amide) salts for cancer treatment
JP5204489B2 (en) 2004-11-19 2013-06-05 シンタ ファーマスーティカルズ コーポレイション Bis (thio-hydrazide amide) to increase HSP70 expression
BRPI0610219A2 (en) 2005-04-15 2010-06-08 Synta Pharmaceuticals Corp methods of treating a human being with cancer and pharmaceutical composition
JP2008540658A (en) 2005-05-16 2008-11-20 シンタ ファーマシューティカルズ コーポレーション Synthesis of bis (thio-hydrazide amide) salts
WO2007021881A1 (en) 2005-08-16 2007-02-22 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation
KR20090045354A (en) 2006-08-21 2009-05-07 신타 파마슈티칼스 코프. Compounds for treating proliferative disorders
AU2007290490B2 (en) 2006-08-31 2011-09-08 Synta Pharmaceuticals Corp. Combination with bis(thiohydrazide amides) for treating cancer
TW200829543A (en) 2006-09-15 2008-07-16 Synta Pharmaceuticals Corp Purification of bis(thiohydrazide amides)

Also Published As

Publication number Publication date
SU461095A1 (en) 1975-02-25
HU164569B (en) 1974-03-28
DE2126304A1 (en) 1972-01-20
FR2097737A5 (en) 1972-03-03
CH548990A (en) 1974-05-15
SU687069A1 (en) 1979-09-25
DE2126304C3 (en) 1979-11-15
CH547787A (en) 1974-04-11
HU164570B (en) 1974-03-28

Similar Documents

Publication Publication Date Title
DE2126304C3 (en) 1-Acylthiosemicarbazides substituted in the 4-position, process for their preparation and medicaments containing them
DE1445186C3 (en) 3,3'-di-2-imidazolin-2-yl-carbanilide
DE1913199B2 (en) Mannich bases from alpha-tetralone or its derivatives and arylalkylamines and their salts
DE2921660A1 (en) 5-NITROIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND ANTIPROTOZONE AGENTS CONTAINING THESE COMPOUNDS
DE2446758B2 (en) 2- (2-Fluoro-6-trifluoromethylphenylaminoMmidazolidine, its acid addition salts, process for the preparation of these compounds and their use in combating hypertension
DE1645906C3 (en) 4 Phenyl 1 piperidin carboxamide, process for their production and pharmaceutical preparations containing them
DE2432392C3 (en) Tris (2-hydroxyethyl) ammonium orthocresoxyacetate, process for its production and pharmaceuticals based on it
DE1445909A1 (en) Process for making urethanes
DE2755061A1 (en) NAPHTHYRIDE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
DE1915535C3 (en) Glyoxaldithiosemicarbazones, processes for their production and pharmaceutical preparations containing them
DE1518125A1 (en) Aminosaeuramides and process for their preparation
DE1795133C2 (en) 5-nitro-8- (5'-bromo-alpha-furoyloxy) -quinaldine, a process for its preparation and pharmaceuticals
DE1645901C3 (en) gamma- (4-alkylp! peridino) -p-fluorobutyrophenones and process for their preparation
DE3129719C2 (en) Pharmaceutical agent
DE1795003C3 (en) 4H-13-Benzoxazin-2-one-3-acetohydroxamic acid, process for their preparation and pharmaceuticals
DE1620393C (en) New isoindolinosulfonylurea compounds and their method of preparation
DE2440378A1 (en) Antiphlogistic and analgesic prepns. - contg. 1,2,4-triazolidin-5-thiones prepd. by reacting hydrazones with alkalithiocyanates
AT236400B (en) Process for the preparation of new benzenesulfonylsemicarbazides
AT251600B (en) Process for the preparation of new oxazolyl urethanes
AT234109B (en) Process for the preparation of new benzenesulfonylsemicarbazides
DE1418540C (en) Process for the preparation of 1,3,2 dioxaborolanes or 1,3,2 dioxabonnanes
DE2027577C3 (en) Glycirrhetinic acid esters, their production and pharmaceutical preparations containing them
DE930208C (en) Process for the production of penicillin salts which are sparingly soluble in water
AT239234B (en) Process for the production of new sulfonamides and their salts
DE1670952C3 (en) ArylsuHonylsemicarbazide, process for their preparation and oral antidiabetic agent

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee